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Abstract
Introduction: Diabetic nephropathy can occur during the course of both type1 and type 2 diabetes
mellitus. The characteristic lesions are diffuse or nodular (Kimmelsteil-Wilson) diabetic glomerulo-
sclerosis. The reported cases represent unusual presentations of diabetes mellitus.
Case presentation: We report the case of a 49-year-old man without prior history of diabetes
mellitus who presented with rapidly progressive renal failure and whose renal biopsy revealed
nodular (Kimmelsteil-Wilson) glomerulosclerosis lesions characteristic of diabetes.
Conclusion: Renal manifestations of diabetes mellitus may antedate other more common presenting
symptoms of this disease and we critically review the literature on this subject.
Introduction
The incidence and prevalence of diabetes mellitus (DM)
are increasing. Tunisia, like most countries of the world, is
experiencing an alarming rise in the number of people
with diabetes. The prevalence of types 2 diabetes in adult
over 30 year of age rose from4.2% in1976 to 10%in 1995
[1]. The situation is similar in other countries. Nowadays,
altogether 120 million people are diabetic in the world
and thenumber will triple in 30 years. Thediabetes-related
medical cost is increasing [2]. DM has become an
enormous social problem. Accordingly, the prevalence of
diabetic nephropathy (DN) is also increasing. It has
become the leading cause of end-stage renal diseases
(ESRD) in developed countries. By USRDS reports [3], the
number of incident patients with diabetes as their primary
cause of renal failure will continue to increase though the
growth rate has slowed a little bit. In Tunisia, it is turning
out to be a major cause of ESRD, diabetic nephropathy
rising at the rate of 16.1% yearly [3,4].
Case presentation
We report the case of a 49-year-old Arabic Tunisian man
without prior history of diabetes mellitus who presented
with rapidly progressive renal failure. Her medical history
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any drugs.
On physical examination, he was afebrile, with a blood
pressure of 120/70 mm Hg and a pulse of 100 beats/min
without orthostatic changes. The chest test was normal and
he had no murmurs or rubs. He had 4+ oedema of his
lower extremities. His skin, scalp, oral mucosa, and
genitals were free of rash or other lesions. The remainder
of his physical examination was unremarkable.
His blood urea nitrogen level was 33.6 mmol/l and
creatinine level was 613 µmol/l, where as electrolyte levels
werenormal.Glucoselevelwas5.1mmol/landuricacidwas
755 µmol/l. Serum protein electrophoresis confirmed the
presence of hypoalbuminemia (22.8 g/l), the total protein
was 56 g/l and demonstrated polyclonal elevation of the
gamma-globulins (13 g/l). The cholesterol was 4.1 µmol/l
and triglycerides was 1.1 mmol/l. Liver function tests were
normal.A24-hoururinecollectionshowed4.74gofprotein.
Urine microscopy showed the presence of red blood cells
(70000/ml).Haemoglobinwas7.1g/dlandhematocritwas
23%,whitebloodcellcountwas8000/µl,andplateletswere
325000/µl. coagulation study results were normal.
Serological evaluation included negative test results for
hepatitis B and C, serum antinuclear antibodies, antineu-
trophil cytoplasmic antibody (ANCA) and anti-glomerular
basement membrane. C3, C4 and CH50 were all in
normal ranges. There was no evidence of dysproteinemia
on serum or urine electrophoresis. Ultrasonography
showed normal-sized kidneys with normal echogenicity.
Regarding the history, the renal function worsened rapidly
from 321 to 613 µmol/l in few days. The urine was 3+ for
protein and 2+ for hematuria. Our patient did not have a
prior diagnosis of DM or other clinical or biological
manifestations of other systemic disease which could be
responsible for the nephropathy. These findings led to the
diagnosis of rapidly progressive glomerulonephritis and
realization of renal biopsy.
The patient was diagnosed as having rapidly progressive
glomerulonephritisandheunderwentanultrasonography-
guided renal biopsy. Light microscopic examination
demonstrated thickening of the glomerular capillary base-
ment membranes with expansion of the mesangial area
and hyalinosis of same afferent and efferent arterioles.
Immunofluorescence did not show anything significant.
Electronicmicroscopywasnotperformed.Therenalbiopsy
specimen revealed nodular (Kimmelsteil-Wilson) glomer-
ulosclerosislesionscharacteristic ofdiabetes.Therefore,we
complete investigation by fundoscopic ophthalmoscopy
witch revealed grade 2 diabetic retinopathy.
After further evaluation, we don’t found classical progres-
sion factors of diabetic nephropathy. The patient has end-
stage renal disease, so he actually was regular dialyzed in
our department.
Discussion
Diabetic nephropathy can occur during the course of both
type 1 and type 2 diabetes mellitus. The characteristic
Figure 1. Nodular (Kimmelsteil-Wilson) glomerulosclerosis
lesions characteristic of diabetes (Masson trichrome
coloration).
Figure 2. Glomerulosclerosis lesions characteristic of
diabetes (Argentic coloration).
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diabetic glomerulosclerosis. It’s the most frequent cause
of renal disease in patients with type II diabetes mellitus
(DM), sometimes accompanied by vascular lesions.
Our patient did not have a prior diagnosis of DM or other
clinical or biological manifestations of other systemic
disease which could be responsible for the nephropathy.
However, her renal biopsy revealed nodular glomerulo-
sclerosis which might indicate an association with DM. In
addition, the diabetic retinopathy found in fundoscopic
ophthalmoscopy confirmed the diagnosis of diabetic
nephropathy. Until now, only few cases have been
reported with this presentation.
Diabetes duration is an indicator of DN in type 2 DM.
Patients with persistent proteinuria and a relatively short
period of diabetes should be examined carefully to
identify non-diabetic renal diseases (NDRD). In DN, it
often takes quite a long period of time to go from micro-
albuminuria to macro-albuminuria, and even renal fail-
ure. DN is one of the chronic complications of diabetes.
Clinical abnormalities are often detected 5-10 years after
onset or diagnosis of DM. The patient with relatively
shorter diabetes duration is probably thought to be
NDRD.
Diabetic retinopathy (DR) is one of the microvascular
complications of DM, which might have the same
pathogenetic pathways as DN. Retinopathy, when it
coexists with nephropathy (usually called renal-retinal
syndrome), is thought to be a window of renal complica-
tion. Diabetic retinopathy may serve as an indicator of
DN. The relationship between retinopathy and nephro-
pathy in type 1 DM has been demonstrated in some
studies [4-6]. In type 2 DM, it was confirmed by Fioretto’s
cohort [7] that almost all microalbuminuric patients had
DR and all patients with proliferative DR had typical DN.
Results of Parving et al. [7,8] showed that all the
proteinuric DM patients with DR had DN. On the other
hand, Parving believed that lack of DR was a poor
predictor of NDRD since the chance for DN or NDRD
was fifty-fifty. The reported cases represent diabetic
nephropathy as the mode of presentation of diabetes
mellitus. Renal manifestations of diabetes mellitus may
antedate other more common presenting symptoms of
this disease [8,9]. The clinical course of patients with
diabetic glomerulosclerosis seems to resemble that of
rapidly progressive glomerulonephritis, so renal biopsy
must be performed.
Though many indicators have been found to be important
distinguishing DN from NDRD in the literature, it is still
unknown how to identify DN effectively, safely and
scientifically. Kidney biopsy is the most effective method
to identify DN in type 2 DM, but it can not be performed
on all the patients due to factors such as anticoagulation,
active bleeding, unilateral nephrectomy or reluctant to
biopsy. Basically, people used to believe that a biopsy had
to be taken to clinically diagnose DN. The diagnosis
criteria were developed as follows: persistent albuminuria,
presence of diabetic retinopathy and absence of any
clinical or laboratory evidence of other kidney or renal
tract disease [7,8]. Also, Glassock [9,10], had presented
biopsy criteria previously, but Serra [10,11] thought these
biopsy criteria were not useful in identifying patients with
other renal diseases. Based on this, some researchers
investigated the frequencies of NDRD in diabetic patients,
and the results varied. The inclusion criteria may play a
role and derive conflicting conclusions.
Conclusion
The reported cases represent diabetic nephropathy as the
mode of presentation of diabetes mellitus. Renal mani-
festations of diabetes mellitus may antedate other more
common presenting symptoms of this disease. We
critically review the literature on this subject, pointing
out the pitfalls in diagnosis and establishing strict criteria
for the diagnosis of diabetic nephropathy in patients
without overt clinical diabetes.
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